News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO>TRANSTHERA-B (02617.HK) IPO Today; Entry Fee $6,641.31
Biopharmaceutical company TRANSTHERA-B (02617.HK) announced the details of its IPO, planning to globally offer 15.281 million shares, with 10% for the Hong Kong public offering and...
Reset
Send
The window will close in 5 seconds
<IPO>TRANSTHERA-B (02617.HK) IPO Today; Entry Fee $6,641.31
Close
Recommend
8
Positive
13
Negative
8
 
SHORT SELL
 
STOCK INFO

Biopharmaceutical company TRANSTHERA-B (02617.HK) announced the details of its IPO, planning to globally offer 15.281 million shares, with 10% for the Hong Kong public offering and 90% for the international offering.

The offer price per share was HKD13.15. Entry fee for each board lot (500 shares) was HKD6,641.31. The IPO starts today (13th) and will close at noon next Wednesday (18th), with the expected listing date on June 23. The joint sponsors are CITIC Securities and Huatai International.

Related NewsGTJAI: Medium to Long-term Uptrend for HK Stocks; Tech Innovation Drives New Productivity Growth as New Momentum
The company introduced five cornerstone investors for the listing, including AKESO (09926.HK)  +0.400 (+0.419%)    Short selling $210.66M; Ratio 12.334%   , collectively subscribing to HKD130 million worth of company shares.

The company expected to raise net proceeds of approximately HKD161 million from the listing.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-06-13 16:25.)

AASTOCKS Financial News
Website: www.aastocks.com
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.